ribavirin has been researched along with Weight Loss in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (53.33) | 29.6817 |
| 2010's | 7 (46.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, Wu; Alam, SE; Arif, A; Sajjad, SF; Waquar, J | 1 |
| Alashinnawy, HA; Alwakeel, HR; Kandil, HM; Matarese, LE; Omar, NA; Rewisha, EA; Taha, AA; Zaghla, HE | 1 |
| Kawano, A; Miyagi, Y; Nomura, H; Tanimoto, H; Yamashita, N | 1 |
| Anzai, K; Eguchi, Y; Fujimoto, K; Iwane, S; Kawaguchi, Y; Kawazoe, S; Kuwashiro, T; Mizuta, T; Nakashita, S; Oeda, S; Otsuka, T; Oza, N; Ozaki, I; Takahashi, H | 1 |
| Fehér, J; Hagymási, K | 1 |
| Chow, DC; Khawcharoenporn, T; Suwantarat, N; Tice, AD | 1 |
| Alegre, SM; Fioravante, M; Lorena, SL; Marin, DM; Pereira, TS; Soares, EC | 1 |
| Hashimoto, K; Nagao, Y; Sata, M | 1 |
| Blanco, F; Garcia-Benayas, T; Soriano, V | 1 |
| Freshwater, DA; Mutimer, DJ; O'Donnell, K; Seyam, MS | 1 |
| Bowler, L; Coates, P; Singh, P; Tahrani, A | 1 |
| Frank, I; Gross, R; Kostman, JR; Lo Re, V; Mounzer, K; Putt, M; Reddy, KR; Rennert, H; Stieritz, DD; Strom, BL; Zemel, BS | 1 |
| Bonkovsky, HL; Dienstag, JL; Everson, GT; Ghany, MG; Lee, WM; Lindsay, KL; Lok, AS; Morgan, TR; Morishima, C; Shiffman, ML; Wright, EC | 1 |
| Bani-Sadr, F; Bensalem, M; Cacoub, P; Carrat, F; Lapidus, N; Melchior, JC; Perronne, C; Pol, S; Ravaux, I; Rosa, I | 1 |
| Cooper, CL; Costiniuk, CT; Mills, E | 1 |
1 review(s) available for ribavirin and Weight Loss
| Article | Year |
|---|---|
Resolution of diabetes in type 2 diabetic patient treated with IFN-alpha and ribavirin for hepatitis C.
Topics: Adult; Antiviral Agents; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Remission Induction; Ribavirin; Treatment Failure; Weight Loss | 2006 |
4 trial(s) available for ribavirin and Weight Loss
| Article | Year |
|---|---|
Weight loss during telaprevir-based triple therapy due to telaprevir-induced appetite loss.
Topics: Antiviral Agents; Appetite; Body Weight; Depression; Drug Therapy, Combination; Female; Genotype; Ghrelin; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Interferon-beta; Male; Middle Aged; Oligopeptides; Polyethylene Glycols; Ribavirin; Treatment Outcome; Weight Loss | 2014 |
Impact of Body Weight Reduction via Diet and Exercise on the Anti-Viral Effects of Pegylated Interferon Plus Ribavirin in Chronic Hepatitis C Patients with Insulin Resistance: A Randomized Controlled Pilot Trial.
Topics: Adult; Antiviral Agents; Body Weight; Diet; Directive Counseling; Drug Therapy, Combination; Exercise; Female; Hepatitis C, Chronic; Humans; Insulin Resistance; Interferon-alpha; Male; Middle Aged; Obesity; Pilot Projects; Prospective Studies; Ribavirin; Treatment Outcome; Viral Load; Weight Loss | 2015 |
Severe weight loss in HIV / HCV-coinfected patients treated with interferon plus ribavirin: incidence and risk factors.
Topics: Adult; Age Factors; Antiviral Agents; Body Mass Index; Drug Therapy, Combination; Female; Hepatitis C; HIV Infections; Humans; Incidence; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Mitochondria; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Factors; Sex Factors; Weight Loss | 2008 |
Evaluation of oral cannabinoid-containing medications for the management of interferon and ribavirin-induced anorexia, nausea and weight loss in patients treated for chronic hepatitis C virus.
Topics: Adult; Anorexia; Antiviral Agents; Cannabinoids; Dose-Response Relationship, Drug; Female; Hepatitis C, Chronic; Humans; Interferons; Male; Middle Aged; Nausea; Retrospective Studies; Ribavirin; Treatment Outcome; Weight Loss | 2008 |
10 other study(ies) available for ribavirin and Weight Loss
| Article | Year |
|---|---|
Weight loss with interferon and ribavirin therapy in chronic hepatitis C patients.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Chi-Square Distribution; Female; Hepatitis C, Chronic; Humans; Interferons; Male; Middle Aged; Pakistan; Ribavirin; Treatment Outcome; Weight Loss | 2012 |
Spontaneous weight change during chronic hepatitis C treatment: association with virologic response rates.
Topics: Adult; Aged; Antiviral Agents; Body Mass Index; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Viral Load; Weight Loss; Young Adult | 2013 |
[Influence of weight reduction on the effectiveness of combined peginterferon and ribavirin treatment in chronic HCV hepatitis].
Topics: Amantadine; Antioxidants; Antiviral Agents; Drug Therapy, Combination; Fatty Liver; Hepatitis C, Chronic; Humans; Insulin Resistance; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Obesity; Polyethylene Glycols; Protective Agents; Recombinant Proteins; Ribavirin; Silymarin; Treatment Outcome; Weight Loss | 2008 |
Weight loss, leukopenia and thrombocytopenia associated with sustained virologic response to Hepatitis C treatment.
Topics: Antiviral Agents; Drug Combinations; Drug Resistance, Viral; Female; Genotype; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Leukopenia; Male; Middle Aged; Polyethylene Glycols; Prognosis; Recombinant Proteins; Retrospective Studies; Ribavirin; Risk Factors; Thrombocytopenia; Time Factors; Weight Loss | 2010 |
Weight loss and resting energy expenditure in patients with chronic hepatitis C before and during standard treatment.
Topics: Adipose Tissue; Adult; Antiviral Agents; Basal Metabolism; Body Fluid Compartments; Body Mass Index; Diet Records; Energy Intake; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Standard of Care; Statistics, Nonparametric; Weight Loss | 2012 |
Candidiasis and other oral mucosal lesions during and after interferon therapy for HCV-related chronic liver diseases.
Topics: Adult; Aged; Antiviral Agents; Candidiasis, Oral; Female; Hepatitis C, Chronic; Humans; Incidence; Interferon-alpha; Lichen Planus, Oral; Male; Middle Aged; Polyethylene Glycols; Prevalence; Ribavirin; Salivary Glands; Serum Albumin; Steroids; Stomatitis; Treatment Outcome; Weight Loss | 2012 |
Weight loss in HIV-infected patients.
Topics: Adult; Anti-HIV Agents; Antiviral Agents; Dideoxynucleosides; Drug Synergism; Drug Therapy, Combination; Female; Hepatitis C, Chronic; HIV Infections; Humans; Interferons; Male; Mitochondria; Ribavirin; Weight Loss | 2002 |
Weight loss during pegylated interferon and ribavirin treatment of chronic hepatitis C*.
Topics: Adult; Aged; Antiviral Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Health Status; Hepatitis C, Chronic; Humans; Interferons; Male; Middle Aged; Polyethylene Glycols; Ribavirin; Weight Loss | 2005 |
Incidence and risk factors for weight loss during dual HIV/hepatitis C virus therapy.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; Cohort Studies; Female; Hepatitis C; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Risk Factors; Weight Loss | 2007 |
Blunted cytopenias and weight loss: new correlates of virologic null response to re-treatment of chronic hepatitis C.
Topics: Ethnicity; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Leukopenia; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Thrombocytopenia; Treatment Outcome; Viral Load; Weight Loss | 2008 |